Details of the Researcher

PHOTO

Keita Tanita
Section
Institute of Multidisciplinary Research for Advanced Materials
Job title
Assistant Professor
Degree
  • Ph.D (Engineering) (Tohoku University)

e-Rad No.
11023713

Research History 6

  • 2025/04 - Present
    Tohoku University Institute of Multidisciplinary Research for Advanced Materials Assistant Professor

  • 2022/11 - 2025/03
    National Institute of Advanced Industrial Science and Technology Research Institute for Chemical Process Technology

  • 2022/04 - 2022/10
    Japan Society for the Promotion of Science

  • 2021/04 - 2022/03
    Japan Society for the Promotion of Science

  • 2019/04 - 2022/03
    Tohoku University

  • 2018/04 - 2019/03
    Tohoku University

Show all Show first 5

Education 3

  • Tohoku University Graduate School of Engineering Department of Biomolecular Engineering

    2019/04 - 2022/03

  • Tohoku University Graduate School of Engineering Department of Biomolecular Engineering

    2017/04 - 2019/03

  • Tohoku University Department of Applied Chemistry, Chemical Engineering and Biomolecular Engineering

    2013/04 - 2017/03

Professional Memberships 2

  • 化学工学会

  • 日本化学会

Awards 4

  1. 令和3年度東北大学工学研究科長賞

    2022/03 東北大学

  2. 科学計測振興基金 令和3年度多元物質科学奨励賞

    2021/12 東北大学 多元物質科学研究所

  3. 令和3年度化学系学協会東北大会 優秀ポスター賞

    2021/10 日本化学会

  4. 第12回多元物質科学研究奨励賞

    2017/12 東北大学 多元物質科学研究所

Papers 14

  1. Temperature-triggered microfluidic fabrication of monodisperse organic particles via LCST-mediated phase transition

    Keita Tanita, Ryuju Suzuki, Hitoshi Kasai, Mao Fukuyama, Akihide Hibara, Takayuki Ishizaka

    RSC Advances 16 (16) 14049-14053 2026

    Publisher: Royal Society of Chemistry (RSC)

    DOI: 10.1039/d5ra08639f  

    eISSN: 2046-2069

    More details Close

    Monodisperse PVA microparticles were obtained from monodisperse droplets. The droplets were generated using a microfluidic device under immiscible conditions of mixed solvent, followed by reprecipitation under miscible conditions.

  2. Overcoming stromal barriers in pancreatic cancer via size-engineered carrier-free nano-prodrugs

    Mengheng Yang, Ryuju Suzuki, Yoshitaka Koseki, Shuto Kodera, Ken Saijo, Hisato Kawakami, Keita Tanita, Sanjay Kumar, Kouki Oka, Hitoshi Kasai

    RSC Pharmaceutics 2026

    Publisher: Royal Society of Chemistry (RSC)

    DOI: 10.1039/d5pm00364d  

    eISSN: 2976-8713

    More details Close

    Carrier-free SNC4DC nanoparticles (30–400 nm) were fabricated by reprecipitation. Smaller particles showed faster SN-38 release and cellular uptake, and 30-nm nanoparticles achieved superior tumor inhibition in pancreatic cancer models.

  3. Newly acylated SN-38 homodimers: carrier-free nano-prodrugs for chemotherapy Peer-reviewed

    Sanjay Kumar, Yoshitaka Koseki, Keita Tanita, Hitoshi Kasai

    Mendeleev Communications 35 (3) 278-281 2025/03

    Publisher: OOO Zhurnal "Mendeleevskie Soobshcheniya"

    DOI: 10.71267/mencom.7664  

    ISSN: 0959-9436

    eISSN: 1364-551X

    More details Close

    Homodimers based on 7-ethyl-10-hydroxycamptothecin (SN-38) containing S<sub>2</sub>[(CH<sub>2</sub>)<sub>2</sub>OC(O)]<sub>2</sub> bridge and acyl substituents were synthesized and used for fabrication of nano-prodrugs. The latter demonstrated remarkable dispersion and stability over one month when stored at a temperature of 4 °C, with an ideal size of nanoparticles in the range of 80-130 nm that is required for EPR effect. The homodimer containing cyclopropylacetyl substituent chain exhibited significant anticancer efficacy against the HCT-116 and A-549 cell lines, with IC50 values having been 0.07 ± 0.01 and 0.29 ± 0.02 μm, respectively.

  4. SN-38-indoximod conjugate: carrier free nano-prodrug for cancer therapy

    Sanjay Kumar, Yoshitaka Koseki, Keita Tanita, Aki Shibata, Asuka Mizutani, Hitoshi Kasai

    THERAPEUTIC DELIVERY 2025/02/02

    DOI: 10.1080/20415990.2025.2458449  

    ISSN: 2041-5990

    eISSN: 2041-6008

  5. SN-38-cholesterol NPs-loaded PDA NPs/agarose & pluronic F-127 hydrogel system for controlled chemo-phototherapy in tumor-localized treatment

    Zhixiang Liu, Yoshitaka Koseki, Mengheng Yang, Keita Tanita, Hitoshi Kasai

    Journal of Materials Chemistry B 13 (34) 10584-10599 2025

    Publisher: Royal Society of Chemistry (RSC)

    DOI: 10.1039/d5tb00994d  

    ISSN: 2050-750X

    eISSN: 2050-7518

    More details Close

    A biocompatible, physically crosslinked hydrogel composed of PF127, agarose, and PDA nanoparticles exhibits NIR-triggered gel–sol transitions and enhanced mechanical properties for controlled drug delivery and photo-chemotherapy.

  6. Carrier-free nano-prodrugs for minimally invasive cancer therapy

    Keita Tanita, Yoshitaka Koseki, Sanjay Kumar, Farsai Taemaitree, Asuka Mizutani, Hirotaka Nakatsuji, Ryuju Suzuki, Anh Thi Ngoc Dao, Fumiyoshi Fujishima, Hiroshi Tada, Takanori Ishida, Ken Saijo, Chikashi Ishioka, Hitoshi Kasai

    NANOSCALE 16 (32) 15256-15264 2024/08/15

    DOI: 10.1039/d4nr01763c  

    ISSN: 2040-3364

    eISSN: 2040-3372

  7. Fabrication of carrier-free heterodimeric nano-prodrugs with podophyllotoxin and SN-38 for a co-delivery system

    Yoshitaka Koseki, Keita Tanita, Motofumi Nakamura, Aki Shibata, Kiyotaka Maruoka, Takaaki Kamishima, Hitoshi Kasai

    MOLECULAR CRYSTALS AND LIQUID CRYSTALS 768 (12) 481-487 2024/08/12

    DOI: 10.1080/15421406.2024.2353966  

    ISSN: 1542-1406

    eISSN: 1563-5287

  8. Anticancer nano-prodrugs with drug release triggered by intracellular dissolution and hydrogen peroxide response

    Aki Shibata, Yoshitaka Koseki, Keita Tanita, Showa Kitajima, Kouki Oka, Kiyotaka Maruoka, Ryuju Suzuki, Anh Thi Ngoc Dao, Hitoshi Kasai

    CHEMICAL COMMUNICATIONS 60 (50) 6427-6430 2024/06/18

    DOI: 10.1039/d4cc02252a  

    ISSN: 1359-7345

    eISSN: 1364-548X

  9. Fabrication of anti-inflammatory nano eye-drops composed of dexamethasone prodrugs

    Keita Tanita, Mai Iijima, Yoshitaka Koseki, Kota Sato, Toru Nakazawa, Hitoshi Kasai

    MOLECULAR CRYSTALS AND LIQUID CRYSTALS 762 (1) 81-87 2023/09/02

    DOI: 10.1080/15421406.2023.2180212  

    ISSN: 1542-1406

    eISSN: 1563-5287

  10. Ir-Catalyzed Cascade Reaction Promotes the Formation of Geometrically Selective Enones from Bis-allyl Alcohols

    Takaaki Kamishima, Yoshitaka Koseki, Hirotaka Nakatsuji, Sanjay Kumar, Keita Tanita, Hitoshi Kasai

    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY 2022 (43) 2022/11/18

    DOI: 10.1002/ejoc.202201002  

    ISSN: 1434-193X

    eISSN: 1099-0690

  11. Development of camptothecin nano-prodrugs based on trimethyl lock groups toward selective drug release in cancer cells

    Aki Shibata, Yoshitaka Koseki, Keita Tanita, Ryuju Suzuki, Anh Thi Ngoc Dao, Hitoshi Kasai

    TETRAHEDRON LETTERS 103 2022/08/03

    DOI: 10.1016/j.tetlet.2022.153989  

    ISSN: 0040-4039

    eISSN: 1873-3581

  12. Fabrication of Hinokitiol-modified podophyllotoxin nano-prodrugs having a high drug loading capacity

    Keita Tanita, Yoshitaka Koseki, Kazue Shimizu, Hirohito Umezawa, Hitoshi Kasai

    MOLECULAR CRYSTALS AND LIQUID CRYSTALS 706 (1) 79-85 2020/07/23

    DOI: 10.1080/15421406.2020.1743441  

    ISSN: 1542-1406

    eISSN: 1563-5287

  13. Tropone Skeleton Enhances the Dispersion Stability of Nano-prodrugs

    Keita Tanita, Yoshitaka Koseki, Takaaki Kamishima, Hitoshi Kasai

    CHEMISTRY LETTERS 49 (3) 222-224 2020/03

    DOI: 10.1246/cl.190876  

    ISSN: 0366-7022

    eISSN: 1348-0715

  14. Influence of Hydrolysis Susceptibility and Hydrophobicity of SN-38 Nano-Prodrugs on Their Anticancer Activity

    Yoshitaka Koseki, Yoshikazu Ikuta, Liman Cong, Mayumi Takano-Kasuya, Hiroshi Tada, Mika Watanabe, Kohsuke Gonda, Takanori Ishida, Noriaki Ohuchi, Keita Tanita, Farsai Taemaitree, Anh Thi Ngoc Dao, Tsunenobu Onodera, Hidetoshi Oikawa, Hitoshi Kasai

    BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 92 (8) 1305-1313 2019/08

    DOI: 10.1246/bcsj.20190088  

    ISSN: 0009-2673

    eISSN: 1348-0634

Show all ︎Show first 5

Industrial Property Rights 1

  1. SN-38誘導体、当該誘導体を含むナノ粒子、医薬及び当該ナノ粒子の製造方法

    笠井 均, 谷田 恵太, 小関 良卓

    特許第7626491号

    Property Type: Patent

Research Projects 1

  1. 緑内障術後の瘢痕化を抑制するナノ粒子点眼薬の開発

    谷田 恵太

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特別研究員奨励費

    Institution: 東北大学

    2021/04/28 - 2023/03/31

    More details Close

    本年度は、抗炎症作用を有するDexamethasone(DEX)を対象に、疎水性の異なるプロドラッグ分子を多数合成し、作製したナノ粒子点眼薬の加水分解耐性および眼内での薬物放出挙動を明らかにした。作製したナノ粒子はそれぞれ炭素鎖長の異なる直鎖ジカルボン酸をリンカーとして導入したプロドラッグ分子のみで構成されている。ブタ肝臓エステラーゼを用いた加水分解耐性試験では疎水性が低い分子設計ほど加水分解されやすく、リンカーの炭素鎖長の長さが大きく関係していた。 眼内を満たす房水は入れ替わりが激しいため、ナノ粒子点眼薬の設計として、眼内に移行後は容易に加水分解され、薬物を放出することが望ましい。作製したナノ粒子の中で最も加水分解耐性の低い、コハク酸(炭素数4)を介したDEX二量体(DEX-C4-dimer)を実際にラットに点眼し、時間毎に房水を採取した。経時変化に伴いナノ粒子が眼内に移行、加水分解していることが確認され、DEX-C4-dimerが迅速な加水分解により活性本体であるDEXを眼内で放出していることを明らかにした。 以上より、炭素鎖長の異なるリンカーを用いて合成された様々なデキサメタゾン誘導体のナノ粒子は、特に加水分解耐性に大きな差が見られ、設計を工夫することで薬物放出挙動を制御することが可能である。今回の研究成果はDEX二量体に限らず、生体内の中でも加水分解酵素が乏しい眼内で迅速に薬物を放出するナノ粒子点眼薬を設計する際の知見として重要である